Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Diabetologia. 2011 Apr 12;54(7):1756–1765. doi: 10.1007/s00125-011-2143-3

Figure 1.

Figure 1

hIAPP release (pmol l−1 islet−1) from hIAPP transgenic islets (a–c) and insulin release (nmol l−1 islet−1) from non-transgenic (open bars) and hIAPP transgenic (solid bars) islets (d–f) cultured for 48 hours in 16.7 mmol/l glucose with no drug (control), exendin-4 (10 nmol/l) or diazoxide (250 μmol/l) (a and d), no drug (control) or KCl (10 mmol/l) (b and e) or no drug (control) or somatostatin (100 nmol/l) (c and f). *p<0.05 vs. control, n=6–9.